A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

Researchers have shown that a spinal cord-stimulating implant, originally used for paralysis, may help restore muscle ...

Three people with a muscle-destroying disease destined to worsen got a little stronger when an implanted device zapped their ...

A new spinal cord implant may help people with spinal muscular atrophy (SMA) regain some muscle function, giving the ...

A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

Electrical stimulation of the spinal cord strengthened the muscles of three people with spinal muscular atrophy, a rare motor neuron disease.

The first-in-human trial saw all three patients able to increase their walking distance within six minutes to 20 meters.

Request To Download Free Sample of This Strategic Report @ Introduction Spinal Muscular Atrophy (SMA) is a rare genetic disorder characterized by the progressive loss of motor neurons, leading to ...

Study using a new, child-friendly scale found patients up to age 2 had smaller mouth openings than healthy peers, risking ...

Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for ...

In a recent study, researchers demonstrated that Z526, a novel dithiocarbamate-like compound, mitigates cancer-associated cachexia (CAC) both in vitro and in vivo.